The Rotavirus Prophylaxis Market Share is a dynamic indicator of the competitive strength and strategic positioning of the major players, reflecting a market that has transitioned from a duopoly to a more diverse, globally contested landscape. Historically, the market was dominated by two multinational pharmaceutical giants: GlaxoSmithKline (GSK) with its monovalent Rotarix, and Merck...